Laddar...
Development of Safe and Non-Self-Immunogenic Mucosal Adjuvant by Recombinant Fusion of Cholera Toxin A1 Subunit with Protein Transduction Domain
Potential use of cholera toxin (CT) as a mucosal vaccine adjuvant has been documented in a variety of animal models. However, native CT is highly toxic to be used as a mucosal adjuvant in humans. Here, we demonstrate a new approach to generate a mucosal adjuvant by replacing the B subunit of CT with...
Sparad:
| I publikationen: | J Immunol Res |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Hindawi
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5863330/ https://ncbi.nlm.nih.gov/pubmed/29707588 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/9830701 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|